Clinical trial reports

Which CROs support European gene therapy phase 1 - 3 trials, and where is outsourced capacity needed most?
How is Event-Free Survival Used in Oncology Trials Authorized in 2024-2026?
Which Kidney Cancer Trial Sites Are Most Active in Phase II–III European CTIS Trials?
Which CROs Support Ovarian Cancer Phase II/III Trials in Europe, and When Are They Needed Most?
Which EU Sites Anchor Phase II/III Bladder and Urothelial Cancer Trials?
Which CROs Support European Depression Phase II–III Trials, and When Are They Needed Most?
Which EU/EEA Sites Lead Infectious Disease Phase 3 Trials?
Which Endpoints Are Measured Most Often in European Psoriasis and Psoriatic Arthritis Phase II & III Trials?
What Are Phase III Haematology CTIS Timelines and What Signals Delay?
Which CROs Support Europe’s Bladder/Urothelial Phase II & III Trial Workload?
Which Endpoints Are Measured Most Often in European Phase II & III Diabetes Mellitus Trials?
Which EU/EEA Sites Lead ADC Phase II/III Trial Participation?